Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer

Background Docetaxel has shown remarkable radiosensitizing propertiesin vitro. In this study we investigated whether the addition of docetaxel to radiotherapy enhanced tumor response in patients with advanced or recurrent breast cancer.